GRADE	Expert agreement
Recommendation 18
The preferred entry site for mesenteric artery revascularization is the femoral artery, followed by the left brachial or radial artery, and is dependent on expertise.	1D	87%
Recommendation 19
In atherosclerotic mesenteric artery lesions, PTA and stenting is recommended over PTA alone.	1D	100%
Recommendation 20
In patients with occlusive disease of both the CA and SMA, endovascular revascularization of both vessels might be attempted. The SMA is the preferred target artery followed by the CA.	2D	91%
Recommendation 21
After endovascular mesenteric artery stenting, we suggest administering dual antiplatelet therapy for at least one month, followed by lifelong antiplatelet monotherapy.	2D	91%
Recommendation 22
In patients treated with DOAC, vitamin K antagonists or LMWH, we suggest adding one antiplatelet agent for 4 weeks after endovascular mesenteric artery stenting.	2D	83%